Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Azitra, Inc.AZTR · Entity 7959 | Director · Chief Operating Officer | April 20, 2026 | April 22, 2026 |
| IN8BIO, INC.INAB · Entity 7941 | Director | December 19, 2024 | December 23, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Azitra, Inc.
Report date April 20, 2026 · Filed April 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right To Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.21 · Expires 2036-04-20 | Direct | 64,300 |
Reported balance
After 2026-04-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-20 · Grant · Acquired 64,300 · Balance 64,300 F1: 1/3rd of the total number of shares of the Company's common stock subject to the option shall vest on the one year anniversary of the date of issuance, the Vesting Commencement Date, and 1/36th of the total number of shares of the Company's common stock subject to the option will vest each calendar month thereafter for the next two years, on the same day of the month as the Vesting Commencement Date. |
Filing footnotes · ownership attribution and instrument terms
F1: 1/3rd of the total number of shares of the Company's common stock subject to the option shall vest on the one year anniversary of the date of issuance, the Vesting Commencement Date, and 1/36th of the total number of shares of the Company's common stock subject to the option will vest each calendar month thereafter for the next two years, on the same day of the month as the Vesting Commencement Date.
IN8BIO, INC.
Report date December 19, 2024 · Filed December 23, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.24 · Expires 2034-12-19 | Direct | 42,676 |
Reported balance
After 2024-12-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-12-19 · Grant · Acquired 42,676 · Balance 42,676 F1: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 20, 2026 Filed Apr 22, 2026 21:29 UTC | Azitra, Inc. AZTR · Entity 7959 | GrantStock Options (Right To Buy) · Derivative | 64,300 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001493152-26-018595 · ownership.xml · derivative · entry 1 Whitfill Travis · CIK 0001830178 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,300 Underlying: Common Stock · 64,300 shares Expires 2036-04-20 F1 · derivative.exercise_date: 1/3rd of the total number of shares of the Company's common stock subject to the option shall vest on the one year anniversary of the date of issuance, the Vesting Commencement Date, and 1/36th of the total number of shares of the Company's common stock subject to the option will vest each calendar month thereafter for the next two years, on the same day of the month as the Vesting Commencement Date. Read SEC document |
| December 19, 2025 Filed Dec 22, 2025 22:28 UTC | Azitra, Inc. AZTR · Entity 7959 | GrantStock Options (Right To Buy) · Derivative | 23,724 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001493152-25-028849 · ownership.xml · derivative · entry 1 Whitfill Travis · CIK 0001830178 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,724 Underlying: Common Stock · 23,724 shares Expires 2035-12-19 F1 · derivative.exercise_date: 25% of the shares of the Company's Common Stock subject to the Option shall vest on the date of issuance, the Vesting Commencement Date, and the remaining balance shall vest in equal monthly installments over the next 36 months of continuous service thereafter. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 21:15 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantStock Option (right to buy) · Derivative | 42,676 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001415889-24-030062 · form4-12232024_041215.xml · derivative · entry 1 Whitfill Travis · CIK 0001830178 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,676 Underlying: Common Stock · 42,676 shares Expires 2034-12-19 F1 · derivative.exercise_date: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 21:00 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantStock Option (right to buy) · Derivative | 33,650 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001415889-24-016970 · form4-06142024_050616.xml · derivative · entry 1 Whitfill Travis · CIK 0001830178 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,650 Underlying: Common Stock · 33,650 shares Expires 2034-06-12 F1 · derivative.exercise_date: One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 12, 2024; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 13, 2024 Filed Feb 16, 2024 01:42 UTC | Azitra, Inc. AZTR · Entity 7959 | PurchaseCommon Stock | 15,000 | $0.30 | $4,500.00 |
DisclosureSEC source: 0001493152-24-006916 · ownership.xml · nonDerivative · entry 1 Whitfill Travis · CIK 0001830178 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,500 Read SEC document |
| September 08, 2023 Filed Oct 3, 2023 20:05 UTC | Azitra, Inc. AZTR · Entity 7959 | GrantStock Options (Right To Buy) · Derivative | 10,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001493152-23-035231 · ownership.xml · derivative · entry 1 Whitfill Travis · CIK 0001830178 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,152 Underlying: Common Stock · 10,000 shares Expires 2033-09-08 F1 · derivative.exercise_date: 25% of the shares of the Company's Common Stock subject to the Option shall vest after 12 months of continuous service measured from 09/08/2023, the Vesting Commencement Date, and the remaining balance shall vest in equal monthly installments over the next 36 months of continuous service thereafter. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 21:28 UTC | Azitra, Inc. AZTR · Entity 7959 | GrantCommon Stock | 250 | $5.00 | $1,250.00 |
DisclosureSEC source: 0001493152-23-022296 · ownership.xml · nonDerivative · entry 1 Whitfill Travis · CIK 0001830178 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250 Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 23:45 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantStock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001209191-23-038122 · doc4.xml · derivative · entry 1 Whitfill Travis · CIK 0001830178 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2033-06-15 F1 · derivative.exercise_date: One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 15, 2023 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| June 01, 2022 Filed Jun 14, 2022 23:00 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantStock Option (right to buy) · Derivative | 10,500 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001209191-22-036801 · doc4.xml · derivative · entry 1 Whitfill Travis · CIK 0001830178 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Common Stock · 10,500 shares Expires 2032-06-01 F1 · derivative.exercise_date: One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 1, 2022 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| June 01, 2022 Filed Sep 23, 2022 21:09 UTC Amendment | IN8BIO, INC. INAB · Entity 7941 | GrantStock Option (right to buy) · Derivative | 13,500 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001209191-22-051164 · doc4a.xml · derivative · entry 1 Whitfill Travis · CIK 0001830178 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2032-06-01 F1 · shares: The original Form 4 inadvertently listed the incorrect number of shares granted to the Reporting Person. F2 · derivative.exercise_date: One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 1, 2022 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date. F1 · derivative.underlying_shares: The original Form 4 inadvertently listed the incorrect number of shares granted to the Reporting Person. F1 · balance_after: The original Form 4 inadvertently listed the incorrect number of shares granted to the Reporting Person. Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 01:36 UTC | IN8BIO, INC. INAB · Entity 7941 | GrantStock Option (right to buy) · Derivative | 10,500 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049165 · doc4.xml · derivative · entry 1 Whitfill Travis · CIK 0001830178 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Common Stock · 10,500 shares Expires 2031-07-29 F1 · derivative.exercise_date: One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on August 29, 2021 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date. The Reporting Person disclaims beneficial ownership of the option except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.